MIR410 Gene

HGNC Family Non-coding RNAs
Name microRNA 410
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐410 (miR‑410) is emerging as a context‐dependent regulator with “split personality” characteristics, functioning either as an oncogene or a tumor‐suppressor depending on the cellular context. Several studies have demonstrated its broad and pleiotropic roles in modulating critical signaling pathways that control cell proliferation, apoptosis, migration, epithelial–mesenchymal transition (EMT), chemoresistance, and even stemness, as well as in normal processes such as lipid metabolism and vascular remodeling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn malignant settings, miR‑410 exhibits dichotomous roles. In some cancers—for instance, in oral squamous cell carcinoma, pancreatic cancer, and breast cancer—it acts as a tumor suppressor by targeting key oncogenic factors (such as Wnt‑7b, AGTR1, and Snail) to inhibit proliferation, invasion, and EMT."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "8"}]}, {"type": "t", "text": " Conversely, in non‑small cell lung cancer, prostate cancer, and subsets of colorectal and osteosarcoma cases, elevated miR‑410 levels promote oncogenic phenotypes—enhancing cell growth, radioresistance, and stemness—by downregulating tumor suppressors such as PTEN, BRD7, and SLC34A2."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "16"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond cancer, miR‑410 regulates a spectrum of non‑malignant processes. For example, it modulates metabolic function by interacting with the lipoprotein lipase pathway and plays a role in retinal vascular homeostasis by directly suppressing VEGFA expression—as shown in studies on retinal neovascularization and retinal pigment epithelium differentiation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": " Its regulatory influence is also evident in endocrine and metabolic disorders such as gestational diabetes, wherein miR‑410 targets lactate dehydrogenase A to aid in pancreatic differentiation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": " Moreover, miR‑410 contributes to immune and inflammatory regulation in autoimmune conditions like systemic lupus erythematosus and rheumatoid arthritis, and it plays roles in neuronal and cardiac injury settings by modulating factors such as PTEN and HMGB1—thereby influencing cell survival, mitochondrial function, and neuroprotection."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "19", "end_ref": "25"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAn additional layer of complexity in miR‑410’s function is provided by its regulation through competing endogenous RNAs. Long non‑coding RNAs such as NEAT1 and NORAD have been shown to sponge miR‑410, thereby modulating its availability and altering downstream signaling in tumors including bladder cancer and osteosarcoma—ultimately affecting NF‑κB activity, chemoresistance, and other oncogenic processes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "28"}, {"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": " Collectively, these observations underscore the intricate, context‑dependent roles of miR‑410 in disease pathogenesis and highlight its promise both as a diagnostic biomarker and as a therapeutic target across a wide range of pathological conditions.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Lingchao Chen, Junhe Zhang, Yan Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-410 regulates MET to influence the proliferation and invasion of glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biochem Cell Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biocel.2012.06.027"}], "href": "https://doi.org/10.1016/j.biocel.2012.06.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22750473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22750473"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Kris Richardson, Jennifer A Nettleton, Noemi Rotllan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2012.10.020"}], "href": "https://doi.org/10.1016/j.ajhg.2012.10.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23246289"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23246289"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Na Chen, Jiaqi Wang, Yijun Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-410 reduces the expression of vascular endothelial growth factor and inhibits oxygen-induced retinal neovascularization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0095665"}], "href": "https://doi.org/10.1371/journal.pone.0095665"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24777200"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24777200"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Dolores Corella, Jose V Sorlí, Ramon Estruch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-410 regulated lipoprotein lipase variant rs13702 is associated with stroke incidence and modulated by diet in the randomized controlled PREDIMED trial."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Clin Nutr (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3945/ajcn.113.076992"}], "href": "https://doi.org/10.3945/ajcn.113.076992"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24990426"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24990426"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ru Wen, Afoma C Umeano, Derek J Essegian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of microRNA-410 in molecular oncology: A double edged sword."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.27251"}], "href": "https://doi.org/10.1002/jcb.27251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30086210"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30086210"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Shine-Gwo Shiah, Jenn-Ren Hsiao, Wei-Min Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulated miR329 and miR410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-14-0978"}], "href": "https://doi.org/10.1158/0008-5472.CAN-14-0978"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25351956"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25351956"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Rende Guo, Jianhua Gu, Zhibin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "IUBMB Life (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/iub.1342"}], "href": "https://doi.org/10.1002/iub.1342"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25646808"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25646808"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Dengrui Li, YongHui Yang, GuiYun Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-410 promotes cell proliferation by targeting BRD7 in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2015.06.031"}], "href": "https://doi.org/10.1016/j.febslet.2015.06.031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26149213"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26149213"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Xuechao Zhang, Xixian Ke, Qiang Pu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.7538"}], "href": "https://doi.org/10.18632/oncotarget.7538"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26910912"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26910912"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Chunyuan Liu, Aihong Zhang, Lei Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR‑410 regulates apoptosis by targeting Bak1 in human colorectal cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2016.5271"}], "href": "https://doi.org/10.3892/mmr.2016.5271"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27177325"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27177325"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Ya-Feng Zhang, Yue Yu, Wang-Zhao Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-410-3p suppresses breast cancer progression by targeting Snail."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2016.4828"}], "href": "https://doi.org/10.3892/or.2016.4828"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27221455"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27221455"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Ren Chen, Xiaohai Li, Bin He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2017.6149"}], "href": "https://doi.org/10.3892/mmr.2017.6149"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28138700"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28138700"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Liyang Dong, Yanan Pu, Lina Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote lung adenocarcinoma growth by transferring miR-410."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-018-0323-5"}], "href": "https://doi.org/10.1038/s41419-018-0323-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29440630"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29440630"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yuelong Zhang, Dahong Zhang, Jia Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.06.176"}], "href": "https://doi.org/10.1016/j.bbrc.2018.06.176"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29969630"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29969630"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yue Yuan, Hu Liao, Qiang Pu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-410 induces both epithelial-mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Signal Transduct Target Ther (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41392-020-0182-2"}], "href": "https://doi.org/10.1038/s41392-020-0182-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32528035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32528035"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Zeng-Hui Ma, Pei-Dong Shi, Bo-Shun Wan "}, {"type": "b", "children": [{"type": "t", "text": "MiR-410-3p activates the NF-κB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cytokine (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cyto.2021.155433"}], "href": "https://doi.org/10.1016/j.cyto.2021.155433"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33517196"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33517196"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Soon Won Choi, Jae-Jun Kim, Min-Soo Seo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-410 Inhibition Induces RPE Differentiation of Amniotic Epithelial Stem Cells via Overexpression of OTX2 and RPE65."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cell Rev Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12015-014-9568-2"}], "href": "https://doi.org/10.1007/s12015-014-9568-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25351180"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25351180"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Yang Mi, Na Guo, Tongqiang He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-410 enhanced hESC-derived pancreatic endoderm transplant to alleviate gestational diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Endocrinol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1530/JME-15-0100"}], "href": "https://doi.org/10.1530/JME-15-0100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26307561"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26307561"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Dongmei Liu, Na Zhang, Xiaomei Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-410 Down-Regulates the Expression of Interleukin-10 by Targeting STAT3 in the Pathogenesis of Systemic Lupus Erythematosus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000445625"}], "href": "https://doi.org/10.1159/000445625"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27351906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27351906"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Xixian Ke, Yue Yuan, Chenglin Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.14529"}], "href": "https://doi.org/10.18632/oncotarget.14529"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28076327"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28076327"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Fan Yang, Tong Li, Zhihuan Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-410 is involved in mitophagy after cardiac ischemia/reperfusion injury by targeting high-mobility group box 1 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.26405"}], "href": "https://doi.org/10.1002/jcb.26405"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28914970"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28914970"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "YueJiao Wang, NeiLi Xu, Shuai Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-410-3p Suppresses Cytokine Release from Fibroblast-Like Synoviocytes by Regulating NF-κB Signaling in Rheumatoid Arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Inflammation (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10753-018-0896-2"}], "href": "https://doi.org/10.1007/s10753-018-0896-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30242542"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30242542"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Hanming Ge, Zhongjun Yan, Haochun Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Mol Pathol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexmp.2019.05.002"}], "href": "https://doi.org/10.1016/j.yexmp.2019.05.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31067440"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31067440"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yuejiao Wang, Linxin Hou, Xiaowei Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA NEAT1 Targets Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via the miR-410-3p/YY1 Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2020.01975"}], "href": "https://doi.org/10.3389/fimmu.2020.01975"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32983133"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32983133"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Diya Sun, Zuoyou Ding, Lei Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-410-3P inhibits adipocyte differentiation by targeting IRS-1 in cancer-associated cachexia patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lipids Health Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12944-021-01530-9"}], "href": "https://doi.org/10.1186/s12944-021-01530-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34563222"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34563222"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Guang Shan, Tian Tang, Yue Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA NEAT1 promotes bladder progression through regulating miR-410 mediated HMGB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109248"}], "href": "https://doi.org/10.1016/j.biopha.2019.109248"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31734579"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31734579"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Xin Xie, Wenjun Liu, Zhiyuan Duan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Biol (Noisy-le-grand) (2020)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32538761"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32538761"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Xuan Liu, Weirong Yao, Haiwei Xiong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biomark (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/CBM-190721"}], "href": "https://doi.org/10.3233/CBM-190721"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32675392"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32675392"}]}]}]}
Synonyms MIRN410, MIR-410, HSA-MIR-410
NCBI Gene ID 574434
API
Download Associations
Predicted Functions View MIR410's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR410's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR410's ARCHS4 Predicted Functions.

Functional Associations

MIR410 has 320 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 17 datasets.

Click the + buttons to view associations for MIR410 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR410 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR410 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR410 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR410 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR410 gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR410 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR410 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR410 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR410 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR410 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MIR410 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of MIR410 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR410 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR410 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR410 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR410 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR410 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.